BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wahlich J, Desai A, Greco F, Hill K, Jones AT, Mrsny RJ, Pasut G, Perrie Y, Seib FP, Seymour LW, Uchegbu IF. Nanomedicines for the Delivery of Biologics. Pharmaceutics 2019;11:E210. [PMID: 31058802 DOI: 10.3390/pharmaceutics11050210] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Waheed S, Li Z, Zhang F, Chiarini A, Armato U, Wu J. Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery. J Nanobiotechnology 2022;20:395. [PMID: 36045386 DOI: 10.1186/s12951-022-01605-4] [Reference Citation Analysis]
2 Chan Y, Singh SK, Gulati M, Wadhwa S, Prasher P, Kumar D, Kumar AP, Gupta G, Kuppusamy G, Haghi M, George Oliver BG, Adams J, Chellappan DK, Dua K. Advances and applications of monoolein as a novel nanomaterial in mitigating chronic lung diseases. Journal of Drug Delivery Science and Technology 2022;74:103541. [DOI: 10.1016/j.jddst.2022.103541] [Reference Citation Analysis]
3 Abdel-Mageed HM, AbuelEzz NZ, Radwan RA, Mohamed SA. Nanoparticles in nanomedicine: a comprehensive updated review on current status, challenges and emerging opportunities. J Microencapsul 2021;38:414-36. [PMID: 34157915 DOI: 10.1080/02652048.2021.1942275] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Rankin-Turner S, Vader P, O'Driscoll L, Giebel B, Heaney LM, Davies OG. A call for the standardised reporting of factors affecting the exogenous loading of extracellular vesicles with therapeutic cargos. Adv Drug Deliv Rev 2021;173:479-91. [PMID: 33862168 DOI: 10.1016/j.addr.2021.04.012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 23.0] [Reference Citation Analysis]
5 Ahmed S, Salmon H, Distasio N, Do HD, Scherman D, Alhareth K, Tabrizian M, Mignet N. Viscous Core Liposomes Increase siRNA Encapsulation and Provides Gene Inhibition When Slightly Positively Charged. Pharmaceutics 2021;13:479. [PMID: 33916066 DOI: 10.3390/pharmaceutics13040479] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
6 Almeida Junior S, Pereira PM, Tótoli VS, Neves ES, Monochio M, Alvarenga AWO, Hori JI, Braz WR, Rocha LA, Nassar EJ, Aldrovani M, Furtado RA. Incorporation of indomethacin into a mesoporous silica nanoparticle enhances the anti-inflammatory effect Indomethacin into a mesoporous silica. Eur J Pharm Sci 2021;157:105601. [PMID: 33115672 DOI: 10.1016/j.ejps.2020.105601] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Abeer MM, Rewatkar P, Qu Z, Talekar M, Kleitz F, Schmid R, Lindén M, Kumeria T, Popat A. Silica nanoparticles: A promising platform for enhanced oral delivery of macromolecules. Journal of Controlled Release 2020;326:544-55. [DOI: 10.1016/j.jconrel.2020.07.021] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 13.0] [Reference Citation Analysis]
8 Anderluzzi G, Perrie Y. Microfluidic Manufacture of Solid Lipid Nanoparticles: A Case Study on Tristearin-Based Systems. DDL 2020;10:197-208. [DOI: 10.2174/2210303109666190807104437] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
9 Magana JR, Sproncken CCM, Voets IK. On Complex Coacervate Core Micelles: Structure-Function Perspectives. Polymers (Basel) 2020;12:E1953. [PMID: 32872312 DOI: 10.3390/polym12091953] [Cited by in Crossref: 13] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
10 Urits I, Swanson D, Swett MC, Patel A, Berardino K, Amgalan A, Berger AA, Kassem H, Kaye AD, Viswanath O. A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis. Neurol Ther 2020;9:301-15. [PMID: 32785879 DOI: 10.1007/s40120-020-00208-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
11 Eleftheriadis GK, Katsiotis CS, Genina N, Boetker J, Rantanen J, Fatouros DG. Manufacturing of hybrid drug delivery systems by utilizing the fused filament fabrication (FFF) technology. Expert Opinion on Drug Delivery 2020;17:1063-8. [DOI: 10.1080/17425247.2020.1776260] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
12 Lin Y, Yu R, Yin G, Chen Z, Lin H. Syringic acid delivered via mPEG-PLGA-PLL nanoparticles enhances peripheral nerve regeneration effect. Nanomedicine 2020;15:1487-99. [DOI: 10.2217/nnm-2020-0042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Solomun JI, Totten JD, Wongpinyochit T, Florence AJ, Seib FP. Manual Versus Microfluidic-Assisted Nanoparticle Manufacture: Impact of Silk Fibroin Stock on Nanoparticle Characteristics. ACS Biomater Sci Eng 2020;6:2796-804. [PMID: 32582839 DOI: 10.1021/acsbiomaterials.0c00202] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Yaroslavov AA, Sybachin AV. Multifunctional carriers for controlled drug delivery. Pure and Applied Chemistry 2020;92:919-39. [DOI: 10.1515/pac-2019-1111] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Castegna A, Gissi R, Menga A, Montopoli M, Favia M, Viola A, Canton M. Pharmacological targets of metabolism in disease: Opportunities from macrophages. Pharmacol Ther 2020;210:107521. [PMID: 32151665 DOI: 10.1016/j.pharmthera.2020.107521] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
16 Eleftheriadis GK, Katsiotis CS, Bouropoulos N, Koutsopoulos S, Fatouros DG. FDM-printed pH-responsive capsules for the oral delivery of a model macromolecular dye. Pharm Dev Technol 2020;25:517-23. [PMID: 31903821 DOI: 10.1080/10837450.2019.1711396] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
17 Salvioni L, Rizzuto MA, Bertolini JA, Pandolfi L, Colombo M, Prosperi D. Thirty Years of Cancer Nanomedicine: Success, Frustration, and Hope. Cancers (Basel) 2019;11:E1855. [PMID: 31769416 DOI: 10.3390/cancers11121855] [Cited by in Crossref: 61] [Cited by in F6Publishing: 82] [Article Influence: 20.3] [Reference Citation Analysis]